Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK

BACKGROUND: Since receiving a positive recommendation in England, Wales and Scotland, tocilizumab (TCZ) is one of the options available to clinicians for the treatment of rheumatoid arthritis (RA) patients in the UK. OBJECTIVE: The objective of this study was to evaluate the cost effectiveness of ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Diamantopoulos, Alex, Finckh, A., Huizinga, T., Sungher, D. K., Sawyer, L., Neto, D., Dejonckheere, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113684/
https://www.ncbi.nlm.nih.gov/pubmed/24854959
http://dx.doi.org/10.1007/s40273-014-0165-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113684/
https://www.ncbi.nlm.nih.gov/pubmed/24854959
http://dx.doi.org/10.1007/s40273-014-0165-7

Ejemplares similares